1.
Journal of Integrative Medicine
;
(12): 175-83, 2013.
Article
in English
| WPRIM
| ID: wpr-450040
ABSTRACT
Microalbuminuria (MAU) is a key component of metabolic syndrome (MetS) and is an early sign of diabetic nephropathy as well. Although routine Western medicine treatments are given to MetS patients to control high blood pressure, hyperglycemia and dyslipidemia, some patients still experience progressive renal lesions and it is necessary to modify and improve the treatment strategy for MetS patients.